Novo Nordisk Foundation to boost pandemic prevention

The Novo Nordisk Foundation wants to arm Denmark against future pandemics, and is granting up to DKK 2bn (USD 310m) to develop an infectious disease center focusing on vaccine development.

Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation | Photo: Gregers Tycho/ERH

In order to strengthen Denmark's defences against future pandemics, and the continued fight against Covid-19, the Novo Nordisk Foundation is establishing a new infectious diseases center in the country.

Danish financial daily Børsen reports that the plans are well underway.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs